Most retinoblastomas initiate in response to the inactivation of the RB1 gene and loss of functional RB protein. The tumors may form without additional genomic changes and develop after a pre-malignant retinoma phase. Despite this seemingly straightforward etiology, mouse models have not recapitulated the genetic, cellular, and stage-specific features of human retinoblastoma genesis. For example, whereas human retinoblastomas appear to derive from cone photoreceptor precursors, current mouse models develop tumors that derive from other retinal cell types. To investigate the basis of the human cone-specific oncogenesis, we compared developmental-stage-specific cone precursor responses to RB loss in human and murine retina cultures and in cone-specific Rb1 knockout mice. We report that RB-depleted maturing (ARR3+) but not immature (ARR3-) human cone precursors enter the cell cycle, proliferate, and form retinoblastoma-like lesions characterized by Flexner-Wintersteiner rosettes, then form low or non-proliferative pre-malignant retinoma-like lesions with fleurettes and high p16 INK4A and p130 expression, and finally form highly proliferative retinoblastoma-like masses. In contrast, in murine retina, only RB-depleted immature (Arr3-) cone precursors entered the cell cycle and they failed to progress from S to M phase. Moreover, whereas the intrinsically highly expressed MDM2 and MYCN contribute to RB-depleted maturing (ARR3+) human cone precursor proliferation, ectopic MDM2 and Mycn promoted only immature (Arr3-) murine cone precursor cell cycle entry. These findings demonstrate that developmental-stage-specific as well as speciesand cell-type-specific features sensitize to RB1 inactivation and reveal the human cone precursors' capacity to model retinoblastoma initiation, proliferation, pre-malignant arrest, and tumor growth.
Introduction
Retinoblastoma is a pediatric retinal cancer that initiates in response to biallelic inactivation of RB1 or MYCN amplification (MYCNA) in a susceptible retinal cell type (1) . RB1-null retinoblastomas are far more common than the MYCNA variety and form either with two somatic RB1 mutations or with one germline and one somatically inactivated RB1 allele. Loss of functional RB protein in the cell-of-origin is thought to enable limited proliferation leading to pre-malignant retinomas, from which rare cells escape to form retinoblastoma tumors (2) .
Retinomas are found at the base of most retinoblastomas, display differentiated histology, and express the senescence markers p16 INK4A and p130. The mechanism of escape from the retinoma stage is currently unknown, but likely does not require further mutations since early tumors may lack genomic changes beyond biallelic RB1 loss (3, 4) . Accurate modeling of retinoma formation and escape may provide opportunities to improve treatment and prevent tumorigenesis in genetically predisposed children. However, genetically engineered animal models have not recapitulated the genetic, cellular, and stage-specific features of human retinoma or retinoblastoma genesis.
In humans, germline RB1 null mutations predispose to retinoblastoma with ~90% penetrance (5) . In contrast, mice with germline Rb1 mutations (6) (7) (8) or chimeric biallelic Rb1 loss (9, 10) fail to develop retinal tumors. Mouse retinal tumors can form when biallelic Rb1 loss is combined with inactivation of Rbl1 (encoding p107) (11) (12) (13) (14) , Rbl2 (encoding p130) (15, 16) , or Cdkn1b (encoding p27) (17) , or when combined with Mycn overexpression ((18) , reviewed in (19) ). However, in contrast to the efficient development of human retinoblastoma from rare RB1-/-cells, murine retinal tumors formed only when millions of retinal cells had Rb1 loss combined with one of the other genetically engineered changes, suggesting that still further genomic changes were needed (16) . Moreover, although the mouse tumors formed Homer-Wright rosettes, which are common to diverse neuronal tumors (20) , they lacked retinoblastomaspecific Flexner-Wintersteiner rosettes and did not progress through a retinoma stage. Furthermore, the mouse tumors prominently expressed retinal interneuron-specific proteins (11) (12) (13) (14) (15) , whereas human retinoblastomas predominantly express cone photoreceptor proteins (21) (22) (23) (24) (25) .
Specifically, in a series of 40 retinoblastomas, the vast majority of RB-deficient cells expressed protein markers of cones but not other retinal cell types (25) . Thus, current mouse models lack the cone protein expression profile, histologic features, and tumorigenesis stages of RB-deficient human retinoblastomas.
The different phenotypes of RB-deficient human retinoblastomas and mouse retinal tumors likely reflect their origins from different retinal cell types. Whereas Rb-deficient mouse retinal tumors were proposed to originate from retinal progenitor cells (14) , from horizontal or amacrine interneurons (11, 26) , or from a multipotent cell capable of producing amacrine and horizontal cells (16) , human retinoblastomas appear to develop from the normally post-mitotic cone precursors that are poised to become mature cone photoreceptors (27, 28) . In keeping with the human tumors' cone-dominant protein profile, RB depletion enabled proliferation of prospectively isolated human cone precursors but not other retinal cells, and proliferation depended on transcription factors (RXR and TR2) and oncoproteins (MDM2 and MYCN) that are highly expressed during human cone maturation (25, 28) . The cone precursors responding to RB loss also expressed maturation markers such as L/M-Opsin and cone arrestin (ARR3) and formed tumors with retinoblastoma-related histology, protein expression, and ultrastructure in orthotopic xenografts (28) . In contrast, mouse models with photoreceptor-specific inactivation of Rb1 or combined inactivation of Rb1, Rbl1, and Tp53 failed to produce cone-derived retinoblastomas (29) , although Rb1 loss at the retinal progenitor cell stage permitted subsequent cone precursor cell cycle entry (11) . These findings suggest that Rb1-null mouse cone precursors lack features that enable extensive proliferation and tumorigenesis in their human counterparts.
To probe the basis for the human but not mouse cone precursors' proliferative response to RB loss, the current study aimed to identify the developmental stage at which human RBdeficient cone precursors proliferate, to characterize murine Rb-depleted cone precursor responses at the equivalent stage, and to determine whether ectopic expression of oncoproteins (MDM2 and MYCN) that are intrinsically highly expressed in human but not mouse cone precursors enables Rb-depleted mouse cone precursor proliferation. The study also examined the longer-term behavior of RB-depleted cone precursors in human retina cultures. Our findings reveal that RB-depleted maturing human but not mouse cone precursors recapitulate important events in human retinoblastomagenesis and that the cone-related MDM2 and Mycn fail to sensitize maturing murine cones to RB deficiency. These findings provide a novel setting in which to explore retinoblastomagenesis mechanisms and suggest that fundamental differences in murine and human cone precursors may challenge the development of ontogenically accurate retinoblastoma models.
Results

RB depletion induces cell cycle entry solely in maturing (ARR3+) human cone precursors.
As prior studies suggested that retinoblastomas originate from cone precursors (28) , we aimed to define the human cone precursor maturation stage that is sensitive to RB loss. Towards this end, human retinae were cultured on a membrane (30) that largely preserves retinal structure and cellcell interactions (Fig. 1A ). With this system, all cell types survived for at least three weeks except Brn3+ retinal ganglion cells, which died within 7 days in culture (DIC) likely due to optic nerve transection (31) . As the retina develops in a central-to-peripheral gradient (32, 33) , these cultures allowed us to assess the effects of RB loss at different cone precursor maturation states as revealed by topographic position and expression of cone maturation markers ( Fig. 1A) . As a proxy for the onset of cone maturation we immunostained for ARR3, whose initial expression was found to coincide with the emergence of cone outer segments and the appearance of apically positioned highly concentrated actin filaments that are implicated in outer segment development ( Fig. S1 ).
To assess the effects of RB loss, retinae were transduced with lentivirus that co-expressed yellow fluorescent protein (YFP) and either a validated RB1-directed short hairpin RNA (shRNA) (pLKO-YFP-shRB733) or a non-targeting "scrambled" shRNA control (pLKO-YFP-shSCR) (28) ( Fig. 1B) . After 12 DIC, retinae were EdU-labeled, sectioned, stained either for RXR to identify all cone precursors (34, 35) or for ARR3 to identify maturing cone precursors; for YFP to identify transduced cells; and either for Ki67 to detect cell cycle entry or for EdU to monitor S phase entry ( Fig. 1A) . In retinae explanted and shRB1-transduced at week 18 and examined at 12 DIC, YFP was detected throughout the retina, indicative of transduction of all retinal layers ( Fig. S2 ). However, as YFP was strongest in the cone-rich outer nuclear layer (ONL), imaging was optimized to resolve YFP+ cells in these regions.
In the more mature central retina, most if not all YFP+,RXR+ cone precursors were Ki67+ and many incorporated EdU (Fig. 1C , D, F). All Ki67+ and EdU+ cells in this region were strongly ARR3+ (Fig. 1E ). In contrast, YFP+,RXR+ cone precursors in the immature peripheral retina lacked ARR3 and failed to express Ki67 or incorporate EdU ( 
Rb loss induces cell cycle entry in immature (Arr3-) but not in maturing (Arr3+) murine cone precursors.
We next asked whether Rb loss enables murine cone precursor proliferation at the same developmental stage as in cultured human retina. To examine effects of Rb loss on murine cone precursors in vivo, we produced mice carrying Cre-dependent Rb1 lox alleles (36) and expressing Cre recombinase under control of the cone-specific red green pigment (RGP, also known as Opn1lw) promoter (37) . The RGP-Cre strain was chosen because the RGP promoter is active in mouse cones beginning at ~ postnatal day (P) 8, soon after the age when murine Arr3 protein is first detected (38, 39) . At both P10 and P28, Rb was readily detected in Rxr+ or Arr3+ cone cells in control Rb1 lox/lox mice but not in RGP-Cre;Rb1 lox/lox littermates ( Fig. 2A and Fig. S4 , white arrows). In contrast, Rb was equally prominent in inner nuclear layer (INL) cells of both genotypes ( Fig. 2A and S4, yellow arrows). Thus, RGP-Cre;Rb1 lox/lox mice were expected to reveal effects of cone-precursor-specific Rb loss beginning at or before P10, soon after the onset of Arr3 expression. However, no Ki67 signal was detected among 2221 Arr3+ or L/M-Opsin+ cones examined at P8, P10, P15, and P28 ( Fig. 2B ). Furthermore, none of 50 RGP-Cre;Rb1 lox/lox mice formed retinal tumors after aging for 6-12 months, and no retinomas or other hyperplasias were detected among three histologically examined retinae. Thus, Rb1 knockout in maturing murine cone precursors failed to induce cell cycle entry or tumorigenesis.
The lack of cone precursor cell cycle entry in RGP-Cre;Rb1 lox/lox mice contrasted with the response of maturing (ARR3+) cone precursors in cultured human retinae. To determine whether maturing murine cone precursors can enter the cell cycle when Rb is depleted ex vivo, under the same conditions as used to examine human retinae, a validated murine Rb1-directed shRNA (40) was delivered into explanted murine retinae using the same YFP-marked lentiviral vector as used for human retina analyses. We first examined effects of Rb knockdown (KD) on murine retinae explanted at P9, similar to the age of Rb1 knockout in RGP-Cre;Rb1 lox/lox mice and after onset of The Rb-deficient Arr3+ murine cone precursors' inability to enter the cell cycle both in vivo (after RGP-Cre-mediated disruption at ~P8) and in vitro (after shRb1 transduction at P9) contrasted with the prior detection of Ki67+ cone precursors at P8 after Rb1 knockout in retinal progenitor cells (11) . In that study, the Ki67+ cone precursors observed at P8 most likely lacked Rb from the time when they were born (between embryonic days (E) 10-16 (41) ) and were immature (Arr3-). To determine if Rb-depletion of immature murine cone precursors can elicit cell cycle entry, murine retinae were explanted and transduced at P4, which is ~ six days after cone genesis is completed (41) and ~ two days before the onset of Arr3 expression ((38) and Fig.   S1 ). Indeed, Rb KD in P4 explants induced Ki67 expression and EdU incorporation in Rxrγ+ cones at 7 DIC ( Fig. 2E , F). However, we detected Ki67+ but not EdU+ cones at 14 DIC and neither Ki67+ nor EdU+ cones at 21 DIC ( Fig. 2F ). As we did not detect cleaved caspase 3+, Rxrγ+ cells (data not shown), the Rb-depleted cone precursors most likely had not died but exited the cell cycle, consistent with the presence of surviving Rb1-/-cone precursors in vivo (11) .
Notably, in P4 explanted retina, Arr3 was induced in a subset of cone precursors after 7 and 14 DIC, indicative of maturation in vitro. However, whereas ~ 5% of Rxr+ cone precursors were Ki67+ at 7 and 14 DIC, no Arr3+ cone precursors were Ki67+ at 7 or 14 DIC ( Fig. 2Eiii and 2F) (0/517 cells examined at 7 DIC (p=0.040) and 0/598 cells examined at 14 DIC (p=0.019), for comparison of Rxr+ and Arr3+ cells at 7 and 14 DIC, respectively; ANOVA with Tukey HSD post-hoc test). Thus, Rb KD at P4 enabled limited cell cycle entry of post-mitotic immature (Arr3-) but not maturing (Arr3+) murine cone precursors.
MDM2 and Mycn promote cell cycle entry of immature but not maturing murine cone precursors.
The cell cycle entry of RB-depleted maturing (ARR3+) human but not murine cone precursors suggested that maturing murine cone precursors lack proliferation-related circuitry that is present in their human counterparts. As ARR3+ human but not mouse cone precursors prominently express MDM2 and MYCN (25) , and as MDM2 and MYCN were critical to the RB-depleted human cone precursors' proliferation (28), we examined whether increased MDM2 and/or Mycn can enable Rb-deficient maturing murine cone precursor proliferation in our in vivo and in vitro models.
Since MDM2 promotes MYCN expression in retinoblastoma cell lines (42) , we first explored whether ectopic MDM2 induces endogenous Mycn expression and Rb-deficient cone precursor proliferation in the RGP-Cre;Rb1 lox/lox background. As MDM2 is initially expressed at the onset of ARR3 expression in the human retina ( Fig. 3A) , we simulated the human cone precursor MDM2 expression timing using an RGP-MDM2 transgene ( Fig. 3B ), which is induced at or soon after the onset of Arr3 expression (38, 39) . The transgene expressed the full-length human MDM2-X1 isoform produced from the p53-regulated MDM2 P2 promoter (43) Thus, in explanted P4 retinae, Mycn T58A induced proliferation in a small proportion of immature cone precursors but did not augment proliferative responses to Rb loss, and failed to enable proliferation of maturing (Arr3+) cone precursors.
RB-depleted human but not mouse cone precursors proliferate and form retinoma-like and retinoblastoma-like lesions.
The above studies indicated that RB-deficient murine and human cone precursors enter the cell cycle at different developmental stages. However, the period of murine cell cycle entry was limited to < 21 days whereas dissociated RB-depleted human cone precursors were reported to remain in the cell cycle in vitro for at least 23 days and to form retinoblastoma-like tumors in orthotopic xenografts (28) . To investigate this discrepancy, we explored whether RB-depleted murine and human cone precursors in explanted retinae merely enter or also complete the cell cycle. We focused on expression of cyclin B1, which normally accumulates in G2 and M, and on the mitosis-associated phospho-histone H3-Ser10 (pH3-S10). In shRB1-transduced human retinae examined at 12 DIC, RXR+ cone precursors expressed cyclin B1 and pH3-S10 in a central to peripheral gradient ( Fig. 5A , C) similar to that of Ki67 and EdU (Fig. 1F ). In contrast, shRb1-and Mycn T58A -transduced RGP-MDM2 mouse cone precursors induced neither cyclin B1 nor pH3-S10 ( Fig. 5B , Table S1 ), implying that Rb-depleted and MDM2-and Mycnoverexpressing immature murine cone precursors can enter but fail to complete the cell cycle.
We next explored the fate of the RB-depleted human cone precursors over extended time in culture. At 30 and 74 DIC, many shRB1-transduced cone precursors, identified by YFP and RXR co-expression, were Ki67+ and EdU+ ( Fig. 6A-D) , although the EdU+ proportion declined relative to that observed at 12 DIC (Fig. 6E) . Moreover, the cultured retinae took on a hyperplastic and disorganized appearance, with abundant rosettes, some of which were clearly Flexner-Wintersteiner rosettes, resembling a retinoblastoma tumor ( Fig. 6F-H) . The Flexner-Wintersteiner rosettes' ring-like distribution of nuclei was also evident in immunostaining analyses ( Fig. 6A -D, yellow circles), which revealed that the rosettes were largely comprised of RXR+ cells, many of which were Ki67+ or EdU+. Flexner-Wintersteiner rosettes were not evident in human retinae transduced with control shSCR and cultured in parallel ( Fig. 6I ), nor in Rb-depleted murine retinae either with or without ectopic MDM2 and Mycn (Fig. S6 ). Some retinal regions also had Ki67+,RXR-cells (i.e., proliferating, non-cone cells); however, some of these were YFP-, indicating that they were not shRB1-transduced ( Fig. 6A, B , white arrows), and similar Ki67+ cells were present in retinae transduced in parallel with the shSCR control ( Fig. S3 and data not shown), suggesting that they represent proliferating retinal progenitor cells or glia as seen at earlier time points ( Fig. S3 and (28) As the increase in non-proliferating RB-depleted cone precursors was consistent with the production of premalignant retinomas (2), we explored whether cultured retina cone precursor lesions had retinoma-associated features including fleurettes (20) and p16 and p130 expression (2) . Indeed, retina transduced with RB1-directed shRNA formed fleurettes within highly RXR+ regions at 74 DIC (Fig. 6J , K) and formed numerous fleurettes that lacked Ki67 but expressed p16 at 123 DIC (Fig. 6L,M) . Moreover, quantitative immunofluorescence imaging revealed that the shRB1-transduced (YFP+) cone precursors at 12 DIC, 30 DIC, and 74 DIC had increased p16 and p130 expression relative to retinae from the fellow eye transduced with shSCR shRNA control ( Fig. 7A-D) . Notably p16 was mainly nuclear in the RXR hi cells that predominated at 12 and 30 DIC and were present at 123 DIC ( Fig. 7C, 6L ) but was mainly cytoplasmic in the RXR lo cells that were more common at 123 DIC ( Fig. 6L ), as reported for patient-derived retinoma samples (2) . In contrast, Rb-depleted murine retinae with ectopic MDM2 and Mycn lacked increased cone precursor p16 or p130 ( Fig. 7E-H) . Thus, maturing human but not murine cone precursors proliferated and formed retinoma-like lesions in response to RB loss.
The above analyses revealed features of retinoblastoma starting at 30 days post RB KD and features of retinoma at 74, 119, and 123 days post-RB KD. To assess whether RB KD can result in full-blown retinoblastoma, we knocked down RB in week 19 and week 21 retinae and cultured for longer times. In two unrelated retinae, cell masses became visible starting at ~ 8 months post-RB KD and were detected in all quadrants by 9 months post-RB KD (Fig. 8A and data not shown). Histologic examination revealed numerous Flexner-Wintersteiner rosettes (Fig.   8B ), consistent with a differentiated retinoblastoma phenotype. The mass was mainly composed of RXRγ+ cells that were in cell cycle as determined by Ki67 expression (Fig. 8C ). Interestingly, cytoplasmic p16 expression was evident in proliferating RXR hi cells that retained differentiated histology (Fig. 8D) , which differed from the nuclear p16 in RXR hi cells at earlier time points ( Fig. 6L, 7C ).
Discussion
We report that RB-depleted human maturing (ARR3+) cone precursors enter the cell cycle, proliferate, and form retinoma-and retinoblastoma-like lesions, whereas Rb-depleted murine immature (Arr3-) cone precursors can enter but not complete the cell cycle ( Fig. 9 ). Maturing Arr3+ murine cone precursors failed to enter the cell cycle both in response to Rb1 knockout in vivo and in response to Rb knockdown initiated either before or after the onset of Arr3+ expression ( Fig. 2) . Moreover, ectopic MDM2 and Mycn did not enable maturing cone precursor cell cycle entry either in vivo or under in vitro conditions identical to those that enabled human cone precursor proliferation ( Fig. 3, 4 ). These findings are consistent with past evidence that murine cone precursors fail to proliferate after photoreceptor-specific Rb1 knockout or combined Rb1, Rbl1, and Tp53 knockout (29) . Thus, maturing (Arr3+) murine cone precursors show an impressive resistance to cell cycle entry, whereas maturing (ARR3+) human cone precursors show an impressive propensity to proliferate under the same conditions. Our findings imply that RB is not needed to enforce cell cycle exit at the time of human cone precursor cell birth, but acquires this role coincident with the onset of ARR3 expression and outer segment growth ( Fig. 9 ). Concordantly, prior analyses indicated that in the human retina, RB is expressed at barely detectable levels in immature cone precursors, and dramatically increases during maturation starting in the fovea at ~ week 14 (reported as post-fertilization week 12, (34)). Rb also was not detected in immature mouse cone precursors from E14 to P5 (45), and was detected at far lower levels during murine versus human cone maturation (25) . Thus, the maturation-associated increase in RB expression correlates with RB's role in suppressing human cone precursor cell cycle entry. If a similar sensitivity pertains in vivo, then the first aberrant proliferation of RB-deficient cone precursors may coincide with the onset of ARR3 expression at ~ week 15 in the central retina (46) , ~ 6 weeks after the first cone precursors are born at ~ week 8 or 9 (47) . A similar interval between cone cell birth and RB-dependent quiescence may apply throughout the retina as cone genesis propagates to the far periphery by week 22 (48) .
In this study, the onset of ARR3 expression was used to denote the transition from an "immature" to a "maturing" cone precursor coinciding with cone outer segment budding. While other maturation-related changes may precede ARR3 expression, early outer segment morphogenesis was proposed to reflect the start of a distinct second phase of vertebrate photoreceptor differentiation (49) . In this regard human cone precursors may become sensitized to RB loss during this second differentiation phase.
Our finding that RB-depleted maturing (ARR3+) but not immature (ARR3-) human cone precursors enter the cell cycle suggests that in the human retina, ARR3 expression is associated with increased mitogenic signaling. Indeed, cone precursor differentiation is associated with increased MDM2 and MYCN in humans but not mice ( Fig. 3 and S5) (25) . Although high MDM2 and MYCN were needed for the human cone precursor proliferative response to RB loss (28) , ectopic MDM2 and Mycn did not enable cell cycle entry in Rb-deficient maturing murine cone precursors ( Fig. 4) . As a caveat, the ectopic Mycn might not have been over-expressed to a sufficient level to enable maturing cone precursor proliferation in these experiments. However, maturing mouse cone precursors were resistant to ectopic Mycn overexpression as compared to maturing human cone precursors transduced with the same methods (H.P. Singh, data not shown), suggesting that additional potentially mitogenic signals enable high-level MYCN expression during human but not murine cone maturation. Indeed, maturing human cone precursors express a larger proliferation-related program, beyond high-level MDM2 and MYCN expression (50) , that could contribute to the proliferative response to RB loss.
While maturing murine cone precursors did not acquire proliferative potential, prior studies suggested that another murine post-mitotic cell typehorizontal cellscan proliferate and form tumors in response to combined biallelic loss of Rb1, biallelic loss of Rbl2 (encoding p130) and monoallelic loss of Rbl1 (p107) (26) . Like maturing human cone precursors, murine Prox1+ horizontal and amacrine cells have intrinsically high Mdm2 (25) , possibly reflecting a similar tumor-prone state. Thus, although the engineered genomic changes were far more extensive, the Rb1-/-;Rbl2-/-;Rbl1+/-model as well as other models in which tumors derive from Prox1+ interneurons might simulate an oncogenic process that is analogous, yet not orthologous, to human retinoblastoma genesis.
In contrast to the proliferative response of RB-depleted maturing human cone precursors, only Rb-depleted immature (Arr3-) murine cone precursors entered the cell cycle (Fig. 2) .
Immature murine cone precursor cell cycle entry was prolonged by ectopic MDM2 and was independently induced by Mycn (Fig. 4 ). However, these responses were weaker than the ~ 60% of human cone precursors that entered the cell cycle in central retina ( Fig. 1F ) and might not be relevant to the development of RB-deficient human retinoblastoma given that the human tumors arise from a distinct developmental stage. The Rb-depleted and MDM2-and Mycnoverexpressing immature murine cone precursors' failure to express cyclin B1 or pH3-S10 ( Fig.   5 ) indicated that they could enter but could not complete the cell cycle. Rb-deficient murine hepatocytes display similar behavior (51), suggesting that certain Rb-deficient mouse cells abrogate cyclin B1 accumulation as a means to suppress Rb-deficient cell proliferation.
However, at present, it is unclear whether human cells are capable of a similar response.
After entering the cell cycle, RB-depleted human cone precursors formed hyperplasias with Flexner-Wintersteiner rosettes and fleurettes, histologic features specific to retinoblastoma and retinoma, respectively (Fig. 6, 7) (2, 20) . Flexner-Wintersteiner rosettes were abundant as early as 30 days post-RB KD and cells within the rosettes expressed cone markers at levels similar to the earliest cone precursors that entered the cell cycle, implying that they are the cone precursors' direct descendants ( Fig. 9 ). Retinoma-like lesions with rare detected at 74, 119, and 123 DIC also expressed cone markers ( Fig. 6 ), suggesting that they derive from Flexner-Wintersteiner-rosette-containing tissue. These lesions had largely cytoplasmic p16, particularly in RXRγ lo cells, as seen in patient-derived retinoma regions (2) . Finally, multiple masses were observed in a pRB-depleted retina after ~ 9 months. The masses had abundant Flexner-Wintersteiner-rosettes and RXRγ expression similar to that observed at 30 DIC ( Fig. 8 ),
resembling differentiated retinoblastoma tissue. The proliferating lesions' predominantly cytoplasmic p16 in RXRγ hi as well as in RXRγ lo cells was a distinct feature of the late-arising retinoblastoma-like versus retinoma-like tissue. Further analyses are needed to assess whether cytoplasmic p16 localization enables the transition from indolent proliferation to differentiated retinoblastoma and whether p16 loss enables a subsequent transition to the de-differentiated retinoblastomas that were reported to have reduced p16 expression (2).
In conclusion, our data supports a model in which human RB-deficient maturing cone precursors initially form proliferative lesions that resemble differentiated retinoblastomas in which the majority of cells exits the cell cycle to form non-proliferating retinomas and a minority remains in the cell cycle, possibly in an indolent state, to form retinoblastoma tumors ( Fig. 9 ).
Understanding the parameters that enable proliferating RB-deficient cone precursors to enter or bypass the retinoma state could provide opportunities to suppress retinoblastoma in genetically predisposed children.
Materials and Methods
Retinal explant culture. Following informed consent, fetal eyes were obtained from authorized sources with approval by the USC and CHLA Institutional Review Board. The best estimate of the gestational age was determined according to the guidelines put forth by the American College of Obstetrics and Gynecology (52) . Post-natal mouse eyes were harvested in retina culture media with the birth day designated P0. Eyes were held on ice for up to 4 h, sterilized in 70% ethanol for 5 seconds, followed by submersion in cold PBS for retina removal. Retinae were harvested as an intact cup, cut radially to flatten, and placed on hydrophilic vectors were obtained from the TRC library (Open Biosystems) or were cloned into the pLKO vector with modifications described before (28) . In addition, the RSV promoter was replaced with CMV promoter to enhance the virus production. We used pLKO.1C-YFP-shRB1-733 (28) for human RB KD and pLKO.1C-YFP-shRb1 (with targeting sequence 5'-AACGGACGTGTGAACTTATAT-3' (40)) for mouse Rb1 KD. pLKO.1C-scrambled (shSCR) expressing a non-targeting control shRNA was Addgene plasmid 1864. The lentiviral cDNA expression vector BE-Neo (or "BN") was as described (28) Cone precursors in the ONL shows brightest YFP signal and were best resolved with exposures optimized for this cell type. Scale bar, 20 µm. 
